These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36046389)

  • 21. [Exploratory study on the detection of markers for diagnosing early-stage malignant mesothelioma].
    Fukuoka K; Tanaka F; Tsujimura T; Hashimoto-Tamaoki T; Hasegawa S; Nakano T
    Nihon Eiseigaku Zasshi; 2011 May; 66(3):553-7. PubMed ID: 21701086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
    Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
    PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin.
    Ak G; Tada Y; Shimada H; Metintas S; Ito M; Hiroshima K; Tagawa M; Metintas M
    BMC Cancer; 2017 Mar; 17(1):212. PubMed ID: 28335760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications.
    Forest F; Patoir A; Dal Col P; Sulaiman A; Camy F; Laville D; Bayle-Bleuez S; Fournel P; Habougit C
    Pathology; 2018 Oct; 50(6):635-641. PubMed ID: 30145072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results.
    Zwijsen K; Schillebeeckx E; Janssens E; Cleemput JV; Richart T; Surmont VF; Nackaerts K; Marcq E; van Meerbeeck JP; Lamote K
    J Breath Res; 2023 Sep; 17(4):. PubMed ID: 37683624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma.
    Creaney J; Dick IM; Meniawy TM; Leong SL; Leon JS; Demelker Y; Segal A; Musk AW; Lee YC; Skates SJ; Nowak AK; Robinson BW
    Thorax; 2014 Oct; 69(10):895-902. PubMed ID: 25037982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Malignant pleural mesothelioma: diagnosis and treatment].
    Delourme J; Dhalluin X; Cortot AB; Lafitte JJ; Scherpereel A
    Rev Pneumol Clin; 2013 Feb; 69(1):26-35. PubMed ID: 23333048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial.
    Katz SI; Roshkovan L; Berger I; Friedberg JS; Alley EW; Simone CB; Haas AR; Cengel KA; Sterman DH; Albelda SM
    Lung Cancer; 2021 Apr; 154():5-12. PubMed ID: 33561782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble markers for diagnosis of malignant pleural mesothelioma.
    Cristaudo A; Bonotti A; Simonini S; Bruno R; Foddis R
    Biomark Med; 2011 Apr; 5(2):261-73. PubMed ID: 21473730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.
    Liu H; Wu L; Ji K; Wang W
    Tumour Biol; 2015 Sep; 36(10):7375-84. PubMed ID: 26361957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.
    Sato H; Soh J; Aoe K; Fujimoto N; Tanaka S; Namba K; Torigoe H; Shien K; Yamamoto H; Tomida S; Tao H; Okabe K; Kishimoto T; Toyooka S
    Int J Oncol; 2019 Jun; 54(6):2139-2148. PubMed ID: 30942424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients.
    Hylebos M; Op de Beeck K; Pauwels P; Zwaenepoel K; van Meerbeeck JP; Van Camp G
    Lung Cancer; 2018 Oct; 124():19-22. PubMed ID: 30268460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesothelioma.
    Raphael J; Massard C; Gong IY; Farace F; Margery J; Billiot F; Hollebecque A; Besse B; Soria JC; Planchard D
    Cancer Biomark; 2015; 15(2):151-6. PubMed ID: 25519011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and pleural fluid biomarkers for mesothelioma.
    Creaney J; Robinson BW
    Curr Opin Pulm Med; 2009 Jul; 15(4):366-70. PubMed ID: 19417672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.
    Rodríguez Portal JA; Rodríguez Becerra E; Rodríguez Rodríguez D; Alfageme Michavila I; Quero Martínez A; Diego Roza C; León Jiménez A; Isidro Montes I; Cebollero Rivas P
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):646-50. PubMed ID: 19190155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Rare Case of Malignant Pleural Mesothelioma in a Young Healthy Male Without Asbestos Exposure.
    Khatib S; Asad O; Asad H; Sabobeh T
    Cureus; 2021 Aug; 13(8):e17199. PubMed ID: 34540427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis.
    Cui A; Jin XG; Zhai K; Tong ZH; Shi HZ
    BMJ Open; 2014 Feb; 4(2):e004145. PubMed ID: 24566531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and prognosis-review of biomarkers for mesothelioma.
    Sun HH; Vaynblat A; Pass HI
    Ann Transl Med; 2017 Jun; 5(11):244. PubMed ID: 28706912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and staging of malignant pleural mesothelioma].
    Sohrab S; Konietzko N
    Pneumologie; 2002 Jun; 56(6):382-7. PubMed ID: 12063622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-asbestos-related malignant pleural mesothelioma.
    Kanbay A; Ozer Simsek Z; Tutar N; Yılmaz I; Buyukoglan H; Canoz O; Demir R
    Intern Med; 2014; 53(17):1977-9. PubMed ID: 25175133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.